MBX Biosciences, Inc.

NasdaqGS:MBX Stock Report

Market Cap: US$799.5m

MBX Biosciences Balance Sheet Health

Financial Health criteria checks 5/6

MBX Biosciences has a total shareholder equity of $54.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $62.9M and $8.4M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$55.26m
EquityUS$54.47m
Total liabilitiesUS$8.41m
Total assetsUS$62.88m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: MBX's short term assets ($58.8M) exceed its short term liabilities ($8.2M).

Long Term Liabilities: MBX's short term assets ($58.8M) exceed its long term liabilities ($212.0K).


Debt to Equity History and Analysis

Debt Level: MBX is debt free.

Reducing Debt: MBX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MBX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MBX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 36.5% each year


Discover healthy companies